Mitochondrial TXNRD3 confers drug resistance via redox-mediated mechanism and is a potential therapeutic target in vivo

Xiaoxia Liu(The People's Hospital of Guangxi Zhuang Autonomous Region), Peng Huang(Wildlife Conservation Society), Shijun Wen(Tibet University), Jing Yang(Sun Yat-sen University), Yanyu Zhang(Peking University), Yi Han(Department of Health and Social Care), Yao Luo(Southeast University), Xin You(Sun Yat-sen University), Yumin Hu(Sun Yat-sen University), Wenhua Lu, Weiye Jiang(Beijing Technology and Business University)
Redox Biology
July 23, 2020
10.1016/j.redox.2020.101652
Cited by 41

Related Papers

Application of Nanoparticles in Enhanced Oil Recovery: A Critical Review of Recent Progress
|Energies|2017|591
Targeting autophagy augments the anticancer activity of the histone deacetylase inhibitor SAHA to overcome Bcr-Abl–mediated drug resistance
|Blood|2007|485
CalDAG-GEFI integrates signaling for platelet aggregation and thrombus formation
|Nature Medicine|2004|406
Bortezomib Inhibits PKR-Like Endoplasmic Reticulum (ER) Kinase and Induces Apoptosis via ER Stress in Human Pancreatic Cancer Cells
|Cancer Research|2005|324
Bortezomib Sensitizes Pancreatic Cancer Cells to Endoplasmic Reticulum Stress-Mediated Apoptosis
|Cancer Research|2005|307